TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Takara Bio Europe AB
Closing information (x1000 SEK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover |
30,479
|
40,421
|
40,446 |
Financial expenses |
1,095
|
899
|
1,669 |
Earnings before taxes |
-5,984
|
-8,798
|
-11,394 |
EBITDA |
-4,423
|
-7,586
|
-9,043 |
Total assets |
44,973
|
33,586
|
41,278 |
Current assets |
22,238
|
21,527
|
28,577 |
Current liabilities |
7,717
|
6,244
|
9,762 |
Equity capital |
27,597
|
17,769
|
9,613 |
- share capital |
2,222
![]() |
2,222
![]() |
2,222 |
Employees (average) |
28
|
26
|
27 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency |
61.4%
|
52.9%
|
23.3% |
Turnover per employee |
1,089
|
1,555
|
1,498 |
Profit as a percentage of turnover |
-19.6%
|
-21.8%
|
-28.2% |
Return on assets (ROA) |
-10.9%
|
-23.5%
|
-23.6% |
Current ratio |
288.2%
|
344.8%
|
292.7% |
Return on equity (ROE) |
-21.7%
|
-49.5%
|
-118.5% |
Change turnover |
-9,942
|
-25
|
1,032 |
Change turnover % |
-25%
|
0%
|
3% |
Chg. No. of employees |
2
|
-1
|
-4 |
Chg. No. of employees % |
8%
|
-4%
|
-13% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.